(Hypertension. 1996;27:693-703.)
© 1996 American Heart Association, Inc.
Articles |
Expression of the Subtype 1A Dopamine Receptor in the Rat Heart
From the Departments of Medicine and Pathology, University of Virginia Health Sciences Center, Charlottesville (R.O., S.J.B., S.F.W., R.A.F., R.M.C.), and Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland (D.P.O., C.V.).
Abstract The subtype 1A dopamine receptor (D1A) has recently been detected in the rat kidney. In the present study using light microscopic immunohistochemistry, electron microscopic immunocytochemistry, and in situ amplification of mRNA, we demonstrate the D1A receptor in Sprague-Dawley and Wistar-Kyoto rat hearts. For immunohistochemistry and immunocytochemistry, anti-peptide polyclonal antibodies were directed toward amino acid sequences of the third extracellular and intracellular domains of the native receptor. Selectivity was validated by recognition of the D1A receptor expressed in stably transfected LTK- cells. D1A receptor mRNA was detected with a novel transcription-based isothermal in situ amplification system as well as with reverse transcription–polymerase chain reaction. D1A receptor protein was distributed throughout the atrium and ventricular myocardium. Preimmune and preabsorption controls were negative. Electron microscopic immunocytochemistry using the protein A gold method demonstrated the D1A receptor along the cellular membranes of coronary smooth muscle cells and ventricular myocytes and in the myosin thick filaments and M-lines. D1A receptor mRNA was present in coronary vessels and myocardium in amplified but not in unamplified sections. Western blot analysis showed specific D1A bands in transfected LTK- cells and the atrium but not in nontransfected LTK- cells and the ventricle. The selective D1-like receptor agonist SKF38393 stimulated adenylyl cyclase in ventricular myocardial plasma membranes in a dose-related fashion, and the response was abolished by the selective D1-like receptor antagonist SCH23390. These results demonstrate that the D1A receptor gene and protein are expressed in normal rat heart. The physiological and pathophysiological roles and predominant cell signaling mechanism or mechanisms of this receptor remain to be determined.
Key Words: dopamine • SKF38393 • rat heart • RNA • in situ amplification • immunohistochemistry • adenyl cyclase
This article has been cited by other articles:
 |
|
 |
|
  G. Ding, R. F. Wiegerinck, M. Shen, A. Cojoc, C. M. Zeidenweber, and M. B. Wagner Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and {beta}2 receptors Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2327 - H2335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Salomone, N. L. Howell, H. E. McGrath, B. A. Kemp, S. R. Keller, J. J. Gildea, R. A. Felder, and R. M. Carey Intrarenal Dopamine D1-Like Receptor Stimulation Induces Natriuresis via an Angiotensin Type-2 Receptor Mechanism Hypertension, January 1, 2007; 49(1): 155 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Trivedi, V. A. Narkar, T. Hussain, and M. F. Lokhandwala Dopamine recruits D1A receptors to Na-K-ATPase-rich caveolar plasma membranes in rat renal proximal tubules Am J Physiol Renal Physiol, November 1, 2004; 287(5): F921 - F931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats Hypertension, May 1, 2001; 37(5): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Gill and O. M. Pulido Review Article: Glutamate Receptors in Peripheral Tissues: Current Knowledge, Future Research, and Implications for Toxicology Toxicol Pathol, February 1, 2001; 29(2): 208 - 223. [Abstract] [PDF]
|
|
|
|
 |
|
 C. J. Vaughan, A. M. Aherne, E. Lane, O. Power, R. M. Carey, and D. P. O'Connell Identification and regional distribution of the dopamine D1A receptor in the gastrointestinal tract Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R599 - R609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ozono, T. Matsumoto, T. Shingu, T. Oshima, Y. Teranishi, M. Kambe, H. Matsuura, G. Kajiyama, Z.-Q. Wang, A. F. Moore, et al. Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R781 - R789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. BARNARD, K. M. RIDGE, F. SALDIAS, E. FRIEDMAN, M. GARE, C. GUERRERO, E. LECUONA, A. M. BERTORELLO, A. I. KATZ, and J. I. SZNAJDER Stimulation of the Dopamine 1 Receptor Increases Lung Edema Clearance Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 982 - 986. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-Q. Wang, R. A. Felder, and R. M. Carey Selective Inhibition of the Renal Dopamine Subtype D1A Receptor Induces Antinatriuresis in Conscious Rats Hypertension, January 1, 1999; 33(1): 504 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ozono, Z.-Q. Wang, A. F. Moore, T. Inagami, H. M. Siragy, and R. M. Carey Expression of the Subtype 2 Angiotensin (AT2) Receptor Protein in Rat Kidney Hypertension, November 1, 1997; 30(5): 1238 - 1246. [Abstract] [Full Text]
|
|
|
|
|
|
R. Ozono, D. P. O'Connell, Z.-Q. Wang, A. F. Moore, H. Sanada, R. A. Felder, and R. M. Carey Localization of the Dopamine D1 Receptor Protein in the Human Heart and Kidney Hypertension, September 1, 1997; 30(3): 725 - 729. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M. Aherne, C. J. Vaughan, R. M. Carey, and D. P. O'Connell Localization of Dopamine D1A Receptor Protein and Messenger Ribonucleic Acid in Rat Adrenal Cortex Endocrinology, March 1, 1997; 138(3): 1282 - 1288. [Abstract] [Full Text] [PDF]
|
|